Effectiveness of Closed Loop Stimulation (CLS) Function for Blood Pressure Drop during Dialysis in an Ordinarily Hypotensive Dialysis Patient with Bradycardiac Atrial Fibrillation
スポンサーリンク
概要
- 論文の詳細を見る
<B>Background:</B> In bradycardiac dialysis, it sometimes becomes difficult for patients to continue hemodialysis treatment because of blood pressure drop due to bradycardia. We have had 3 cases where a pacemaker (PM) with CLS function was effective. <B>Purpose:</B> We present one case where we implanted a PM with CLS function (Nihon Kohden, BIOTRONIK) in a 77-year-old male patient with ordinary hypotension and bradycardiac atrial fibrillation and investigated the effectiveness of CLS function. <B>Methods:</B> We measured blood pressure changes and heart rate response during dialysis and compared them between CLS and acceleration sensor modes. <B>Results:</B> In ordinary hypotension, in VVI-CLS mode, heart rate variation was observed during dialysis. When systolic pressure (Ps) dropped from 70 mmHg to 64 mmHg, pacing rate increased 13 ppm and Ps recovered promptly. In acceleration sensor VVIR mode, PR remained at 60 ppm. <B>Discussion:</B> In VVI-CLS setting, we believe that myocardial contraction dynamics changed in response to blood pressure drop and changed intracardiac impedance, and thereby CLS function increased PR and recovered and maintained blood pressure early. <B>Conclusion:</B> For blood pressure drop in dialysis patients who have ordinary hypotension of 60 to 70 mmHg and bradycardiac atrial fibrillation, CLS function appears to increase its pacing rate responsively.
著者
-
Takahashi Ryuichi
Department Of Cardiovascular Surgery Saiseikai Utsunomiya Hospital
-
Hashizume Kenichi
Department Of Cardiovascular Surgery Keio University School Of Medicine
-
Ishikawa Norio
Nihon Kohden
-
Suzuki Takao
Jichi Medical University Hospital
-
Arie Tsuyoshi
NIHON KOHDEN CORPORATION
-
Matsumoto Teruhiko
NIHON KOHDEN CORPORATION
-
Takahashi Nobuharu
NIHON KOHDEN CORPORATION
関連論文
- Sinus Bradycardia with Heart Rate Lower than the Programmed Lower Rate Limit in a Patient with an Implanted VDD Pacemaker
- Modeling Nonlinear Evolution of Baryon Acoustic Oscillations : Convergence Regime of N-body Simulations and Analytic Models
- The Limitation of Staged Repair in the Surgical Management of Congenital Complex Heart Anomalies with Aortic Arch Obstruction
- Effect of Post-Ischemic Hypothermia on Spinal Cord Damage induced by Transient Ischemic Insult in Rabbits
- Primary Repair of Complete Transposition of the Great Arteries With Complete Atrioventricular Septal Defect
- Free Right Internal Thoracic Artery as a Second Arterial Conduit : Modification of Proximal Anastomosis for Improvement of Graft Patency
- Aortic Intramural Hematoma With Severe Aortic Regurgitation
- Aortic Subannular Left Ventricular Aneurysm in a Patient of Asian Ancestry
- Effect of the Free Radical Scavenger MCI-186 on Spinal Cord Reperfusion after Transient Ischemia in the Rabbit
- Effect of Delayed Induction of Postischemic Hypothermia on Spinal Cord Damage Induced by Transient Ischemic Insult in Rabbits
- Risk factor analysis for acute type A aortic dissection after aortic valve replacement
- Third-Order Density Perturbation and One-Loop Power Spectrum in Dark-Energy-Dominated Universe(Astrophysics and Cosmology)
- Lens Model Degeneracy and Cosmological Tests by Strong Gravitational Lensing
- Rice phenolics efflux transporter 2 (PEZ2) plays an important role in solubilizing apoplasmic iron(Plant nutrition)
- Effectiveness of Closed-Loop Stimulation (CLS) Function in Circulating Blood Volume Variation during Dialysis in Bradycardiac Dialysis Patients
- Effectiveness of Closed Loop Stimulation (CLS) Function for Blood Pressure Drop during Dialysis in an Ordinarily Hypotensive Dialysis Patient with Bradycardiac Atrial Fibrillation
- Rate Response Function of Pacemaker with Closed-Loop Stimulation (CLS) to Blood Pressure Variation during Dialysis in a Bradycardia Patient
- Closed-Loop Stimulation (CLS) Pacing Treatment for Hypotension during Dialysis in Bradycardiac Dialysis Patient: Comparison between VVI and VVI-CLS
- EFFECTIVENESS OF A NEW ANTILEUKEMIC AGENT, THIOINOSINE (6-MERCAPTOPURINE RIBOSIDE)